Название продукции:N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide
IUPAC Name:N-[(2S,3R,4E)-3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide
- CAS：170212-26-7
- Молекулярная формула：C36H59N5O11
- Чистота：95%+
- Номер в каталоге：CM573150
- Молекулярная масса：737.89
| Упаковочная единица |
Доступно для заказа |
Цена ($) |
Количество |
Только для использования в НИОКР..
Информация о продукции
- Номер CAS:170212-26-7
- Молекулярная формула:C36H59N5O11
- Точка плавления:-
- Smiles-код:CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCNC1=CC=C(C2=NON=C12)[N+]([O-])=O
- Плотность:
- Номер в каталоге:CM573150
- Молекулярная масса:737.89
- Точка кипения:
- Номер Mdl:MFCD03453619
- Хранение:
Category Infos
- Benzofurazans
- Benzofurazans are important pharmaceutical intermediates. Benzofurazans are known bioisosteres of the nitro group. Both oxadiazoles and nitro groups have strong electron-withdrawing properties, but when optimizing drug-like properties such as activity, selectivity, and stability, the absence of standard charges in the oxadiazole structure may be more beneficial to drug products. What's more, nitro groups have been identified as toxic groups, and it is routine to remove or replace them in the early stages of drug development.
Поиск 
+86 21 5895 0110 
